Newmedical Spółka z Ograniczoną Odpowiedzialnością (KRS 0000454490, NIP 5862281732) is a Polish company, headquartered in Gdańsk, Pomorskie voivodeship. Newmedical operates in: Activities of head offices; management consultancy activities (PKD 70.10.B). Industry: Consulting and management. The company has been listed in the National Court Register since March 13, 2013.
Negative equity
Negative equity in 3 of 8 available reporting years.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Newmedical
Identity
- Name
- Newmedical Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- Limited Liability Company (LLC)
- Founded
- March 13, 2013
- Registry status as of
- July 24, 2026
- Latest entry
- July 24, 2026
- Founding act
- NA NADZWYCZAJNYM ZGROMADZENIU WSPÓLNIKÓW SPÓŁKI W DNIU 09.11.2017R., Z KTÓREGO PROTOKÓŁ SPORZĄDZIŁA NOTARIUSZ JOANNA BOC…
Articles of association history (9)
- 11-03-2013
- November 9, 2017: NA NADZWYCZAJNYM ZGROMADZENIU WSPÓLNIKÓW SPÓŁKI W DNIU 09.11.2017R., Z KTÓREGO PROTOKÓŁ SPORZĄDZIŁA NOTARIUSZ JOANNA BOCIANOWSKA (REP. A NR 4096/2017), DOKONANO ZMIANY § 3 UMOWY SPÓŁKI
- June 15, 2018: 15.06.2018 R., REPERTORIUM A NR 3475/2018, NOTARIUSZ JACEK WRONA, KANCELARIA NOTARIALNA JACEK WRONA, AL. NIEPODLEGŁOŚCI 746/1, 81-840 SOPOT, §5,§6
- April 19, 2021: 19.04.2021 ROKU, REPERTORIUM A NR 2180/2021, KANCELARIA NOTARIALNA NOTARIUSZ KALINA BARTECKA, UL. LEGIONÓW 116A/4, 81-472 GDYNIA ZMIENIONO : §1,§5,§6,§15 AKT NOTARIALNY Z DNIA 11.05.2021R., REPERTORIUM A NR 7160/2021, NOTARIUSZ TOMASZ BINKOWSKI UL. UPHAGENA 21/3, 80-237 GDAŃSK, ZMIENIONO §3 UMOWY SPÓŁKI, §6 UMOWY SPÓŁKI
- June 23, 2022: 23.06.2022, REPERTORIUM A NR 2922/2022, NOTARIUSZ KATARZYNA WILKOWSKA, ALEJA NIEPODLEGŁOŚCI 746/1, 81-840 SOPOT, ZMINA PAR. 3, PRZYJĘTO TEKST JEDNOLITY
- October 23, 2024: 23.10.2024, REPERTORIUM A NR 3938/24, NOTARIUSZ KATARZYNA WILKOWSKA, ALEJA NIEPODLEGŁOŚCI 746/1, 81-840 SOPOT, ZMIANA UMOWY SPÓŁKI PRZEZ UCHYLENIE W CAŁOŚCI DOTYCHCZASOWEJ UMOWY I PRZYJĘCIE NOWEJ TREŚCI UMOWY SPÓŁKI.
- May 21, 2025: 21.05.2025, REPERTORIUM A NR 1845/2025, NOTARIUSZ KATARZYNA WILKOWSKA, ALEJA NIEPODLEGŁOŚCI 746/1, 81-840 SOPOT, ZMIANA § 14 UMOWY SPÓŁKI ORAZ PRZYJĘCIE TEKSTU JEDNOLITEGO UMOWY SPÓŁKI.
- December 30, 2025: 30.12.2025, REPERTORIUM A NR 3083/2025, NOTARIUSZ ALICJA GŁÓDŹ, PARTYZANTÓW NR 14 LOK. 2, 80-254 GDAŃSK, ZMIANA § 3 I § 6 UMOWY SPÓŁKI
- June 24, 2026: 24.06.2026, REPERTORIUM A NR 3163/2026, NOTARIUSZ RAFAŁ KAPKOWSKI, UL. WILCZA 1 LOK. 9, 80-822 GDAŃSK, ZMIANA § 3, § 8 ORAZ § 8A UMOWY SPÓŁKI I PRZYJĘCIE TEKSTU JEDNOLITEGO UMOWY SPÓŁKI
Activities
Other activities
Address and contact
- Address
- UL. MARYNARKI POLSKIEJ, 59, 80-557, GDAŃSK, POLSKA
- Voivodeship
- POMORSKIE
- District
- GDAŃSK
- BIURO@NMEDICAL.PL
- Website
- WWW.NMEDICAL.PL
- E-delivery address
- AE:PL-21634-90617-JFIVW-18
Risk and payment profile - Newmedical
Credibility rating
58.9 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
6
6/13 yrs
Board changes
4
4/13 yrs
PKD changes
3
3/13 yrs
Name changes
0
0/13 yrs
Data from 13 years of registry activity.
Credibility history
Payment reliability score from 2018–2025
Current: C (59/100)
Trend: deteriorating (-9.1 pts/year)
Moderate payment credibility - the company is able to meet its obligations, but some indicators warrant caution.
Trade credit limit history
Standard limit from 2018–2025
Current: 121.6 K PLN
Safe: 54.7 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Newmedical
Founded
March 13, 2013
13 years in operation
Legal form
Limited Liability Company (LLC)
Registry: RejP
Headquarters
GDAŃSK
POMORSKIE
Primary PKD
70.10.B
Activities of head offices; management consultancy activities
Share capital
2.0 M PLN
40,000 shares total
Shareholders
1
shareholder
Board
2 people
Proxies: 1
Filed years
8 years
2018–2025 · profitable: 5/8
Registry entries
47
latest: July 24, 2026
Risk signals
Revenue
N/A
2025
Net profit
337.8 K PLN
2025
Assets
22.9 M PLN
2025
Equity
N/A
2025
EBITDA
N/A
2025
no depreciation data
Valuation
2.8 M PLN
Low confidence
Low confidence
Board and connected people - Newmedical
People holding roles at Newmedical according to the Polish National Court Register. Follow a name for that person's full profile and their other companies.
- Marcin KrzemińskiPresident of the board
- Mariusz Jerzy StanisławczykPresident of the board, Majority shareholder
- Karol GrzeżułkowskiBoard member, Majority shareholder
- Wojciech Adam KempińskiBoard member, Shareholder
- Artur Piotr KarpezoMajority shareholder
- Maria Teresa KempińskaMajority shareholder, Commercial proxy
- Marzena KarpezoMajority shareholder
Directories and rankings for this location
Public procurement
Trademarks
Reviews
Rate business credibility - Newmedical.
No ratings
Related articles
News
Agora in 2026: return to dividends after 6 years (PLN 0.25), EBITDA of PLN 148m, PLN 200m strategic target
Agora S.A. - the Warsaw-based media holding (Gazeta Wyborcza, the Helios cinema chain, Radio TOK FM and Złote Przeboje, AMS outdoor, Yieldbird) - paid its first dividend in six years (PLN 0.25 per share, PLN 11.65m in total). The 2026–2029 strategy targets a cumulative PLN 2.50 per share in dividends and lifts EBITDA from PLN 148m to PLN 200m.
News
Archicom: a PLN 1.80 per share dividend recommendation after a record 2025 - 2,847 apartments sold, three times the market growth
Wrocław-based Archicom S.A. (KRS 0000555355) closed 2025 with revenue of PLN 961.7 m (+30% YoY), standalone net profit of PLN 229.9 m and 2,847 apartments sold (+30% YoY versus market +9.3%). The board recommends a PLN 1.80 per share dividend (PLN 105.3 m); the final decision rests with the AGM (scheduled for July 2026). The 2026 target: 3,200-3,500 units plus a debut in the Tricity. The first full year under Echo Investment control (74.04%) after the 2023 integration.
